Encounter for screening for other viral diseases
The new codes are for describing the infusion of tixagevimab and cilgavimab monoclonal antibody (code XW023X7), and the infusion of other new technology monoclonal antibody (code XW023Y7).
Search the full ICD-10 catalog by:
Immunodeficiency following hereditary defective response to Epstein-Barr virus. D82. 3 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM D82.
9.
Z02.1ICD-10 Code for Encounter for pre-employment examination- Z02. 1- Codify by AAPC.
For asymptomatic individuals who are being screened for COVID-19 and have no known exposure to the virus, and the test results are either unknown or negative, assign code Z11. 59, Encounter for screening for other viral diseases.
Z00. 00, Encounter for general adult medical examination without abnormal findings, Z00.
Other specified counselingICD-10 code Z71. 89 for Other specified counseling is a medical classification as listed by WHO under the range - Factors influencing health status and contact with health services .
CPT® 80307, Under Presumptive Drug Class Screening Procedures. The Current Procedural Terminology (CPT®) code 80307 as maintained by American Medical Association, is a medical procedural code under the range - Presumptive Drug Class Screening Procedures.
Z00.00ICD-10 Code for Encounter for general adult medical examination without abnormal findings- Z00. 00- Codify by AAPC.
Z02.1Encounter for pre-employment examination Z02. 1 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2022 edition of ICD-10-CM Z02. 1 became effective on October 1, 2021.
There are three codes for COVID-19 testing: 87635 is designed to detect the COVID-19 virus and effective March 13, 2020, and 86328 and 86769 will be used to identify the presence of antibodies to the COVID-19 virus and are effective April 10, 2020.
DIAGNOSIS CODES FOR COVID-19 ANTIBODY TESTING Report code Z01. 84, “Encounter for antibody response examination,” if the antibody test is neither to confirm a current COVID-19 infection nor for follow-up of a known infection.
These codes are therefore an assumption of how it was likely being reported. Note: The new code Z11. 52 (Encounter for screening for COVID-19) effective 1/1/21, is not appropriate for screening until the pandemic is declared over (per January 2021 updated guidelines I.C.